source
- Experts discuss why anti-CCR8 antibody denikitug is being tested in phase 1 solid tumor trialsDr Bruno B. Bockorny, a gastrointestinal oncologist at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School, explained the scientific basis for testing the anti‑CC…
- Panel reviews clinical trial landscape and new strategies for recurrent endometrial cancer after checkpoint inhibitor failureA recent expert panel has examined the current state of clinical trials targeting recurrent endometrial cancer. The discussion highlighted that many patients now face disease progression after rec…